Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open, Multi-centre Trial Evaluating Acceptance of the New Liquid Growth Hormone Formulation - Norditropin® SimpleXx® in Children With GH Deficiency

NCT00567385 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT00567385
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00567385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open, Multi-centre Trial Evaluating Acceptance of the New Liquid Growth Hormone Formulation - Norditropin® SimpleXx® in Children With GH Deficiency
Lead sponsor
Novo Nordisk A/S
Phase
Phase 4
Overall status
Completed
Start date
March 10, 2003
Completion date
March 22, 2004
Enrollment
176 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

growth hormone deficiency in children, growth hormone disorder